Taken together, ILG significantly attenuated neurological dysfunction in experimental PD, and the mechanisms may be through activation of the Nrf2/NQO-1 signaling pathway to alleviate neuroinflammation. The gene discussed is NQO1; the disease is Parkinson disease.